Bladder Regeneration is a pioneering area in regenerative medicine that aims to restore or replace damaged bladder tissues, addressing conditions such as bladder dysfunction, trauma, or congenital anomalies. Traditional treatments often involve surgical interventions or tissue grafts, but bladder regeneration seeks to provide more sophisticated and long-lasting solutions. Biotechnological approaches in bladder regeneration involve the use of stem cells, biomaterials, and tissue engineering strategies. Stem cells, including mesenchymal stem cells or induced pluripotent stem cells, are employed to differentiate into specific bladder cell types, fostering tissue repair and regeneration. Biomaterials such as biodegradable scaffolds or matrices play a crucial role in providing structural support and promoting cell attachment and growth. These scaffolds can be designed to mimic the native extracellular matrix, enhancing the integration of regenerated tissues with the existing bladder. Bladder regeneration also explores the use of growth factors and signaling molecules to stimulate cell proliferation and differentiation. Advances in gene therapy enable the targeted delivery of therapeutic genes, influencing cellular functions critical for tissue repair. Clinical trials and research studies on bladder regeneration are ongoing, exploring the safety, efficacy, and long-term outcomes of these innovative approaches. Challenges include achieving functional and durable tissue regeneration and ensuring compatibility with the complex physiological environment of the bladder. The development of successful bladder regeneration strategies holds great promise for improving the quality of life for individuals with bladder-related disorders and advancing the field of regenerative medicine.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States